SUTRO BIOPHARMA, INC. (STRO) Marketable Securities, Current USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Sutro Biopharma, Inc. quarterly Marketable Securities, Current history and growth rate from 2018 to 2024.
  • Sutro Biopharma, Inc. Marketable Securities, Current for the quarter ending March 31, 2024 was $202 M, a 7.09% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $202 M +$13.4 M +7.09% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $264 M +$9.32 M +3.66% Dec 31, 2023 10-Q 2024-05-13
Q3 2023 $239 M +$48.7 M +25.6% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $123 M +$10.7 M +9.5% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $189 M +$46.5 M +32.6% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $255 M +$125 M +95.7% Dec 31, 2022 10-K 2024-03-25
Q3 2022 $191 M +$31.3 M +19.7% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $113 M -$54.5 M -32.6% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $143 M -$22 M -13.4% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $130 M +$10 M +8.31% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $159 M +$21.2 M +15.4% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $167 M +$31 M +22.8% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $164 M +$92.6 M +129% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $120 M +$7.44 M +6.59% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $138 M +$24.8 M +21.9% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $136 M +$2.24 M +1.68% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $71.8 M -$72.1 M -50.1% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $113 M +$33.7 M +42.6% Dec 31, 2019 10-K 2021-03-18
Q3 2019 $113 M +$31.6 M +38.7% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $134 M Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $144 M Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $79.2 M Dec 31, 2018 10-K 2020-03-16
Q3 2018 $81.6 M Sep 30, 2018 10-Q 2018-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.